In their ongoing efforts to improve health outcomes, decrease health care costs, and increase administrative efficiency, health care agencies are increasingly investing in information-based technologies (IT). Recently, the Canadian government highlighted the need for developing new methods for evaluating new health sector technologies in order to provide insight into the challenges associated with increased use of IT in health care settings. This award supports the development of a team that is researching the use of IT for epidemiological data collection (EDC), also known as e-epidemiology. The team’s goals include: identifying technological, organizational, governance and implementation challenges associated with the increased use of IT for EDC; addressing data quality issues arising from increased use of IT for EDC; and improving collaborations among researchers, decision makers and technology developers across disciplines who share an interest in e-epidemiology. The team hopes to improve the quality of evidence used in decision making about information technologies used for collecting epidemiological data in BC.
To examine the economic costs of asthma in terms of the societal costs (quality of life, lost work days, etc), including the incremental cost-effectiveness of using newer, more expensive drugs that better manage asthma symptoms.
Researchers at the centre are using tissue microarray technology to systematically validate whether certain biomarkers – cellular or molecular substances found in cancers – can be used to improve cancer diagnostics or predict the course of disease. With the ability to test hundreds of tumour samples at a time, researchers can assess the potential value of potential biomarkers with an efficiency that would have been unimaginable just a few years ago.